Patients Blueprints for UK pharma-NHS joint working Joint working could hold at least part of the answer to getting the NHS back on its feet after COVID, according to the ABPI.
Views & Analysis Tackling multimorbidity through collaboration As populations age, multimorbidity becomes an increasingly pertinent issue for healthcare systems.
Views & Analysis Sharing success to unlock the “triple win” of joint working The fortunes of the NHS and the UK’s life sciences industry are intertwined, with each sector’s success or failure heavily dependent on the other.
News MSD, Eisai report setback in first-line kidney cancer trial The LITESPARK-012 trial saw no benefit when Welireg was added to treatment with Keytruda plus Lenvima for renal cell carcinoma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
